Recent GH Stock Price | GH Stock Predictions | |
$16.39 | +148.02% |
$40.65 |
Recent GH Analyst Ratings Breakdown, Making GH Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 15 | 15 | 15 | 15 |
Buy ratings: | 2 | 2 | 2 | 2 |
Hold ratings: | 2 | 2 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.29 | 1.29 | 1.29 | 1.29 |
For the GH stock predictions from the analysts covering Guardant Health Inc, we have collected all of the individual GH stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 17 different analysts covering GH (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since GH stock predictions may vary widely, another useful metric to consider is the median GH stock prediction, which represents the price at which half of the analysts
made GH stock predictions that were higher and half made GH stock predictions that were lower. This makes for a different take on the GH stock predictions out there, as compared to average or mean.
And that median across all the individual GH stock predictions was: $44.0 as of 2024-04-18.
The very highest of the GH stock predictions for one year price target was $64.0, while the very lowest of the GH stock predictions in the analyst group was
$27.0 (with a standard deviation of $9.999). Get the latest Zacks research report on GH — FREE
Find out: GH next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
PUMP Stock Predictions
MT Stock Predictions
COUP Stock Predictions
COR Stock Predictions
BRKS Stock Predictions
GMRE Stock Predictions
DBD Stock Predictions
BJRI Stock Predictions
MCBS Stock Predictions
|
|
Strong Buy (3.71 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |